1. Hamilton AM, Kohner EM, Rosen D, et al. Experimental retinal vein occlusion in rhesus monkeys. I. Clinical appearance. Br J Ophthalmol. 1979; 63:377–87.
2. Hockley DJ, Tripathi RC, Ashton N. Experimental retinal vein occlusion in rhesus monkeys. III. Histopathological and electron microscopical studies. Br J Ophthalmol. 1979; 63:393–411.
3. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res. 2008; 33:111–31.
Article
4. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984; 98:271–82.
5. Weiter JJ, Zuckerman R. The influence of photoreceptor-RPE complex on the inner retina: explanation for beneficial effect of photocoagulation. Ophthalmology. 1980; 87:1133–9.
6. Prendiville PL, McDonell PJ. Complications of laser surgery. Int Opthalmol Clin. 1992; 32:179–204.
Article
7. Sanghvi C, McLauchlan R, Delgado C, et al. Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol. 2008; 92:1061–4.
Article
8. Cho BJ, Kim TW, Woo SJ, et al. Short-term clinical outcome of patterned scanning laser photocoagulation0 with short exposure time in diabetic retinopathy. J Korean Ophthalmol Soc. 2009; 50:376–82.
9. L'Esperance FA. Ophthalmic lasers. 3rd ed.1. St Louis: CV Mosby Co.;1989. p. 78–112.
10. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976; 2:175–84.
Article
11. Lee DG, Cho NC. Combination of laser treatment and intravitreal triamcinolone injection for macular edema with branch retinal vein occlusion. J Korean Ophthalmol Soc. 2005; 46:287–96.
12. Yang HN, Kim YJ, Kim JC, Shin KH. Clinical evaluation for branch retinal vein occlusion. J Korean Ophthalmol Soc. 1992; 33:599–604.
13. Arnarsson A, Stefnsson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2004; 41:877–9.
14. Mainster MA. Decreasing retinal photocoagulation damage; principles and techniques. Semin Ophthalmol. 1999; 14:200–9.
Article
15. Al-Hussainy S, Dodson PM, Gibson JM. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye. 2008; 22:96–9.
Article
16. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation. Can the laser heal the retina without harming it? Semin Ophthalmol. 2004; 19:62–8.
17. Jain A, Blumenkranz MS, Paulus Y, et al. Effects of pulse duration on size and character of lesion in retinal photocoagulation. Arch Ophthalmol. 2008; 126:78–85.
18. Blumenkranz MS, Yellachich D, Andersen DE, et al. Semiautomated patterned scanning laser for retinal photocoagulation. Retina. 2006; 26:370–6.
Article
19. Doft BH, Blankenship GW. Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 1982; 89:772–9.
Article
20. Mainster MA, Sliney DH, Belcher CD, Buzney SM. Laser photo-disruptors: damage mechanisms, instrument design and safety. Ophthalmology. 1983; 90:973–91.
21. Schuele G, Rumohr M, Huettmann G, Brinkmann R. RPE damage thresholds and mechanisms for laser exposure in microsecond to millisecond time regimen. Invest Ophthalmol Vis Sci. 2005; 46:714–9.
22. Roseman RL, Olk RJ. Krypton red laser photocoagulation for retinal branch vein occlusion. Ophthalmology. 1987; 94:1120–5.
23. Lee UK, Park YH, Han DK. Argon laser photocoagulation for neovascularization in retinal vein occlusion. J Korean Ophthalmol Soc. 1998; 39:1478–84.